Estimating the Absorbed Dose to Critical Organs During Dual X-ray Absorptiometry by Mokhtari-Dizaji, M et al.
102 Korean J Radiol 9(2), April 2008
Estimating the Absorbed Dose to 
Critical Organs During Dual X-ray
Absorptiometry
Objective: The purpose of this study is to estimate a patient’s organ dose
(effective dose) during performance of dual X-ray absorptiometry by using the
correlations derived from the surface dose and the depth doses in an anthropo-
morphic phantom. 
Materials and Methods: An anthropomorphic phantom was designed and
TLDs (Thermoluminescent Dosimeters) were placed at the surface and these
were also inserted at different depths of the thyroid and uterus of the anthropo-
morphic phantom. The absorbed doses were measured on the phantom for the
spine and femur scan modes. The correlation coefficients and regression func-
tions between the absorbed surface dose and the depth dose were determined.
The derived correlation was then applied for 40 women patients to estimate the
depth doses to the thyroid and uterus. 
Results: There was a correlation between the surface dose and depth dose of
the thyroid and uterus in both scan modes. For the women’s dosimetry, the aver-
age surface doses of the thyroid and uterus were 1.88  Gy and 1.81  Gy, respec-
tively. Also, the scan center dose in the women was 5.70  Gy. There was correla-
tion between the thyroid and uterus surface doses, and the scan center dose.
Conclusion: We concluded that the effective dose to the patient’s critical
organs during dual X-ray absorptiometry can be estimated by the correlation
derived from phantom dosimetry.
steoporosis is the most common cause of bone fractures in women, and
especially during their menopausal period (1, 2). Bone densitometry is an
effective tool for assessing the risk of bone fracture. Today, it is also
possible to control bone density during the healing period. Dual-energy X-ray absorp-
tiometry (DXA) is the most applicable method to assess bone density, and this also
allows for the determination of the bone mineral density (BMD) and bone mineral
content (BMC). Radiation protection standards have been developed with the advent
of bone densitometry, which utilizes ionizing radiation. Previous studies have shown
that for performing bone densitometry with the DXA method, the radiation dosage to
critical organs is due to scattered radiation; the surface doses from different DXA
systems (pencil, fan and cone beams) have also been measured and compared. A
recent study measured the values of the surface doses originating from a cone beam of
the new DXA systems (3). 
Due to radiation protection and the ALARA (As Low As Reasonably Achievable)
standards, the assessment of radiation exposure requires performing radiation dosime-
try (4). Manufacturers usually place emphasis on the surface dose, but this quantity is
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Onot enough to estimate the patients’ risk. It is also
necessary to determine the absorbed and effective doses.
The majority of studies in the field of dosimetry that
have used DXA systems have compared surface doses
from pencil and fan beams (5, 6). The patients’ effective
dose was calculated in those studies on the systems that
utilize a fan beam, and the effective dose was proven to be
smaller than that using other conventional radiography
techniques (7, 4). A bone equivalent humanoid spine
phantom was used in several previous studies to evaluate
the surface doses from systems with a fan beam (5, 6, 8-
12). The surface doses on two phantoms that were five and
10 years old, respectively, from a system with a pencil
beam, were measured using TLDs (Thermoluminescent
Dosimeters). In that study, the TLDs showed a small value
(~0) for the absorbed dose. The necessity of utilizing
dosimetry for these systems was nonetheless highlighted
(13). In another study, it was shown that the effective dose
from a fan beam was about two times greater than that
from a pencil beam. However, those values are still smaller
than the effective dose of the conventional radiography
methods (14, 15). In another study that aimed to estimate
the embryo radiation doses and the risks associated with
spinal and hip DXA, it was shown that the use of an apron
resulted in a very small change in the absorbed dose to the
embryo (16).
Today’s DXA systems have evolved from using pencil
and fan beams to using cone beam densitometers, which
allows for an examination to occur without any scanning
and with a short acquisition time. It was shown that the
patient and staff doses from DXA systems are low (3).
Although new methods for bone densitometry have been
developed, there have been no studies to estimate the
absorbed dose to critical organs on the basis of the surface
dose using DXA systems. Therefore, in this study, a tissue
equivalent anthropomorphic phantom was irradiated with
the femur and spine protocols. Using TLDs that were
placed at the surface and at different depths of the thyroid
and uterus, the absorbed dose of a Lunar DPX-MD densit-
ometer with a pencil beam was measured. Forty women
also underwent bone densitometry with a Lunar DPX-MD
system, which utilizes a pencil beam, in the posteroanterior
(PA) spine and femur scan modes. The surface doses of the
thyroid, uterus and center of the scan point were measured
using TLDs. The percentage of surface dose per unit dose
to the center of the scan for the thyroid and uterus was
then calculated. Based on the correlation coefficients and
linear regression functions between the phantom surface
dose and the dose at different depths, the thyroid and
uterus depth doses were then estimated. The correlation
between the scan center dose and surface dose to critical
organs was then calculated. Finally, the effective doses to
the thyroid and uterus were compared with the
background radiation dose.
MATERIALS AND METHODS
DPX-MD Densitometer
The Lunar DPX-MD is one of the most widely used DXA
machines. It uses a pencil X-ray beam that’s detected after
passing through the patient. Both the X-ray source and
detector traverse the scanning area with a rectilinear
motion. The DPX-MD (Lunar Corp., DPX series, Lunar
MD 7164, WI, with a scan speed of 1 mm/s and a resolu-
tion of 0.5 0.5 mm) has a highly stable potential X-ray
generator with a k-edge filter. The two X-ray energies
required to differentiate between soft tissue and bone are
produced using this filter. The X-ray tube is operated at 76
kVp and it has a maximum current of 5 mA. The effective
energies of the beam are 38 and 70 keV. The operating
current of the system is 0.75 mA. Its filtration is 35 mm-Al
and the maximum field size is 10 10 mm
2. The distance
from the focal spot of the X-ray tube to the patient is
33.0 33.5 cm and the distance from the focal spot to the
detector is 58.2 cm. The system is capable of evaluating
bone density in the spine and femur, and it is also used for
total body protocols. In spine scan mode, the scan area is
20 18 cm
2 with a maximum line scan of 167 lines and a
scan width of 18 cm. The scan width is 15 cm in the femur
scan mode. The scanned-area BMD and BMC data can be
displayed with the DPX-MD software (version 4). 
Various scanning modes (slow, medium and fast) can be
used depending on the weight/thickness of the abdomen of
the patient and the required resolution. In this study, the
slow mode was assessed, which has a longer exposure
time. 
TLD Measurement Technique
Radiation dosimetry measurements were made using
cubic calcium flouride TLDs (3 3 1 mm
3). The TLDs
(TLD-400; Harshaw/Bicron, Solon, OH) were initially
sorted into groups of equal sensitivity by a calibration
procedure. The first step in this procedure was to obtain
the ECCs (Element Correction Coefficients), which were
applied in order to increase the reproducibility because of
the individual differences between the TLD responses. On
average, TLD badges have variations in the range of 10-
15% which, after applying ECCs, was reduced to about 1-
2%. We exposed 18 TLDs (76 kVp, 100 cm FFD, 100 mA,
0.01 S) and obtained their responses (xi), and we calculated
the mean of their responses (xAV) in nC (nano Coulombs).
The ECC for each TLD was obtained from the equation:
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xi
To obtain the calibration equation, we used 20 TLDs: six
groups of three TLDs and two TLDs for background
radiation measurements. These six groups were exposed to
13.94, 31.40, 44.23, 70.79, 92.80 and 133  Gy. The
readout procedure was done using a TLD reader (TLD
reader, Harshaw 3500). To obtain each of these doses, a
multimeter (Unfors 401, Sweden) with accuracy of 
1  Gy was placed in the radiation field. To increase the
accuracy and reproducibility, each exposure was repeated
three times. The TLDs were then annealed for one hour at
500 C (Atash 1200 Exiton Corp., Iran). According to the
results, the dose ( Gy) versus reading (nC) was plotted,
and a calibration curve was obtained (Fig. 1).
To increase the measurement and calculation accuracy,
we created four groups that each consisted of three TLDs,
and the three TLDS in each group were exposed to 21.23,
56.05, 80.23 and 105.7  Gy, respectively, and these dose
values were measured by a multimeter. After reading and
applying the ECCs and obtaining dose values from the
calibration equation, mean values for each group were
calculated as 23.41, 57.08, 78.36 and 103.98  Gy.
Calculated versus real values were plotted, and a correc-
tion factor was obtained (Fig. 2).
Anthropomorphic Phantom
To estimate the absorbed dose to critical organs at differ-
ent depths versus the surface dose, we used an anthropo-
morphic phantom that consists of three parts: the head and
neck, the abdomen and the pelvic areas. This phantom was
designed and constructed at the Iran University of Medical
Sciences. Natural bone was used in the construction of this
phantom. Paraffin wax with NaCl (impurity) was used as a
substitute for soft tissues. The effective atomic number and
electron density of the soft tissue material were 6.57 and
3.36 10
23 g
1, respectively. For the lungs, two spongy
woods were prepared with dimensions similar to the lungs,
but with lower density than the soft tissue. Several probes
made of phantom material that had TLDs located at differ-
ent depths (with 1 cm intervals) were constructed for the
dosimetry of the critical organs (Fig. 3).
Phantom Measurement
Phantom dosimetry was done using two different
protocols for the spine and femur, respectively. The
scanning conditions were complementary to the normal
scan modes. First, a PA spinal scan was done in slow mode
with 450 mAs; the absorbed dose to thyroid, uterus and
scan center (the lumbar region) were then measured at the
organ surface and the different depths (Fig. 4). To reduce
error, each badge consisted of three TLDs. To measure the
thyroid dose in this scan, badges with three TLDs were
prepared and placed at the right and left lobes of the
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Fig. 1. Calibration curve of TLDs.
Fig. 2. Correction factor curve for TLDs.
Fig. 3. Front view of anthropomorphic phantom with depth
probes.thyroid at the surface and at different depths. One badge
was placed at the scan center. Two additional TLDs were
used to measure the background radiation outside the
room. After applying the correction and calibration coeffi-
cients for each TLD, the dose to each region was then
calculated in  Gy. We then applied X-ray quality factor
and thyroid weighting factor to obtain the effective dose
equivalent in  Sv. To estimate the surface and depth doses
to the phantom in the uterus region in PA spine scan
mode, TLD badges were placed at the surface and at 12.5
cm, 17.5 cm and 22 cm depth within the phantom. To
reduce error, each scan was repeated four times. Because
the uterus and ovaries are in the same region, radiation
quality factor and tissue weighting factor were applied and
their contribution to the dose equivalent was assessed.
In the femur scan protocol, that is, in the slow mode with
270 mAs, only the uterus dose was assessed due to the
very low thyroid exposure, which was found to be in the
range of the background radiation (a large distance from
the thyroid to the femur center of the scan). To measure
dose values, badges with three TLDs were placed at ten
different depths in the uterus, and this included the surface,
9.5, 10.5, 11.5, 12.5 (center of uterus), 14.5, 15.5, 16.5,
17.5 (above uterus) and 22 cm from the source. To reduce
error, the femur scan was repeated five times. After
acquisition of the dose values, correlations between the
depth and the surface dose of the critical organs were
assessed. In cases where the correlation coefficients were
significant, linear regression analysis was done to estimate
the depth dose of critical organs versus their surface dose. 
Patient Measurement
The patients included in this study consisted of 40
women who were referred to the Iran Metabolism and
Endocrine Research Center for bone densitometry. This
study was performed from Jan 2005 to Feb 2006 and it
was approved by the Ethics Committees of the Iran
Metabolism and Endocrine Research Center (Iran). First, a
list of each patient’s characteristics including age, height,
weight, body thickness and body mass index (BMI) was
obtained along with written consent before each experi-
ment (Table 1). The system current for each patient was
proportional to the patient’s BMI in each of the PA spine
and femur protocols (397 57 mAs). The number of femur
scan lines for each patient was proportional to their weight
and height. 
In the PA spine scan, the area between the first and forth
vertebrae (L1-L4) was scanned. To assure the accuracy of
the patient position, a scan was also done from T12-L5. In
the femur scan, one of the patient’s legs was rotated from
ankle eversion. The patient measurements badges were
placed at the following locations: two badges at the scan
center (between L1-L4), two at the location of the thyroid
lobes, two at the location of the uterus and two at the
center of the femur scan position. All of these badges were
placed at the surface and on the posterior side of the
patient to measure the surface dose. Two badges were
used to monitor the background radiation. For each
patient, a scan protocol that included the PA, spine and
femur modes was utilized. The patient entrance dose at the
location of the critical organs and the dose at the scan
center were measured together with the background
radiation using TLDs. After acquiring the dose values,
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Table 1. Mean and Standard Deviation of Patients’
Characteristics
Age Height Weight Thickness BMI
(yr) (cm) (kg) (cm) (kg.m
3)
55 12 157 76 7 10 20 2 26.3 4.4
Note. BMI = body mass index
Table 2. Mean and Standard Deviation of Surface Dose (Ds) and Depth Dose of Thyroid (Dd; depth length, cm), Scan Center
and Background Doses ( Gy)
Right Lobe (n* = 24) Left Lobe (n = 24)
Scan Center (n = 12) Background (n = 8)
Dd (7 cm) Ds (0) Dd (7 cm) Ds (0)
1.16  0.15 1.21  0.20 1.23  0.27 1.37  0.27 6.15  1.22 1.01  0.25
Note. * Number of measurements
Fig. 4. Anthropomorphic phantom in measurement position.correlations between the dose at the scan center and the
surface dose at critical organs were assessed. If the correla-
tion coefficient was significant, then linear regression
analysis was done to estimate the dose to critical organs
versus the dose at the scan center. These organs are not in
the scan direction; therefore, their absorbed dose is due to
scattered radiation from other tissues. The percentage
surface dose (D) to an organ was calculated based on the
organ surface dose (D0) and the total radiation dose of
each scan (Dt) and the scan center dose with using the
following equation: 
D =
D0  100
Dt
The depth dose to the thyroid and uterus was estimated
from the values of the previous phantom studies. The
contribution of these organs to the effective dose (HE
[ Sv]) was summed from the following equation:
HE = 
n
T=1 
HT WT
where HT is the dose equivalent and it is derived from the
product of the absorbed dose ( Gy) and the radiation
quality factor (for X-rays, the quality factor is unity). WT is
a tissue weighting factor, which differs for different tissues. 
All of the statistical analyses were calculated with SPSS
(SPSS/PC Inc; Chicago, version 11.5). P-values less than
0.01 were chosen as the level of statistical significance.
RESULTS
Phantom
The results of the thyroid dose in the PA spine scan
mode are shown in Table 2. The TLD badges were placed
at the right and left lobes (at the surface and depth) and at
the scan center and the results were analyzed after each of
four runs.
In this scan, the average thyroid dose was 1.28 0.25 
Gy for the left lobe and 1.18 0.17  Gy for the right
lobe. By applying a thyroid weighting factor (0.05), the
effective dose for the left and right lobes was found to be
0.06 0.01  Sv and 0.06 0.02  Sv, respectively.
Correlation analysis was performed to obtain a relation-
ship between the depth and surface dose in the thyroid.
When the correlation coefficient was significant, a linear
regression function was obtained. The results from the
linear regression analysis are shown in Table 3.
However, in this study, there was no significant correla-
tion between the thyroid dose and the dose at the scan
center.
To assess the uterus dose in the PA spine scan mode, the
absorbed dose at four depths in the uterus (four times for
each protocol and using three TLDs in each badge) was
measured. The results from assessing the uterus depth dose
at zero distance (at the surface near the source), 12.5 cm
(center of uterus), 17.5 cm (above the uterus) and 22 cm
(the surface at the anterior position of phantom) from the
source, the background dose and the dose at the scan
center are shown in Table 4.
In this scan, the uterus average dose in the PA spine scan
mode was 1.21 0.33  Gy. According to the similar
position of the uterus and ovaries and taking into account
the uterus and ovaries weighting factors of 0.05 and 0.20,
respectively, their contribution to the effective dose was
0.06 0.02  Sv for the uterus and 0.24 0.07  Sv for the
ovaries.
Pearson correlation and linear regression analysis were
applied to obtain the correlation between the depth and
Mokhtari-Dizaji et al.
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Table 3. Linear Regression Functions and Correlation
Coefficients for Independent Variable of Surface
Dose (Ds) and Dependent Variable of Depth Dose
(Dd) for Thyroid
Organ
Linear Regression  Correlation 
Functions Coefficient
p value
Thyroid left lobe Dd = 0.57 Ds+0.61 0.69 0.014
Thyroid right lobe Dd = 0.47 Ds+0.62 0.65 0.024
Table 4.  Mean and Standard Deviation of Surface Dose (Ds) and Uterus Depth Dose (Dd; depth length, cm) at Zero Distance (at
Surface Near Source), 12.5 cm (Center of Uterus), 17.5 cm (above Uterus), 22 cm (Surface at Anterior Position of
Phantom), Dose at Scan Center and Background Dose ( Gy): PA Spinal Scan Mode
Ds (n* = 12) Dd (12.5) (n = 12) Dd (17.5) (n = 12) Dd (22.0) (n = 12) Scan Center (n = 12) Background (n = 8)
1.13  0.21 1.21  0.33 1.29  0.42 1.16  0.19 6.58  1.19 1.04  0.34
Note. * Number of measurements
Table 5. Linear Regression Functions and Correlation
Coefficients for Independent Variable of Surface
Dose (Ds) and Dependent Variable of Depth Dose
(Dd; depth length, cm) for Uterus at Different 
Depths
Linear Regression  Correlation  Significant 
Function Coefficient Level
D12.5 = 0.94 Ds+0.14 0.60 0.039
D17.5 = 1.52 Ds+0.44 0.77 0.003
D22.0 = 0.76 Ds+0.30 0.86 0.000surface doses in the uterus. Table 5 shows the regression
functions between the depth and surface dose in the uterus
with their significance levels and correlation coefficients.
There was no significant correlation between the uterus
surface dose and the depth dose and the dose at the scan
center (p-value < 0.05).
In the femur scan protocol, uterus dosimetry (with 270
mAs exposure) was done at 10 different depths; this
included the surface dose (near the source), 9.5, 10.5, 11.5,
12.5 (center of the uterus), 14.5, 15.5, 16.5, 17.5 (above
the uterus) and 22.0 cm from the surface. To reduce the
error, the femur scan protocol was repeated five times.
Table 6 shows the results from the analysis of doses at
different depths. In this protocol, the dose at the scan
center and the background dose were 7.38 2.27  Gy and
2.23 1.25  Gy, respectively. In this protocol, the uterus
absorbed dose was 2.52 1.12  Gy. After applying the
uterus and ovary weighting factors, their contributions to
the effective dose equivalent were found to be 0.13 0.06
Sv and 0.50 0.22  Sv, respectively.
To evaluate a linear regression between the absorbed
uterus dose at the surface and at different depths, correla-
tion regression analysis with linear regression was
performed with the results being given in Table 7.
Patient
The surface dose of the thyroid, uterus, center of the
scan and background in the PA spine and femur scan
modes for 40 women (patients) with using 120 TLDs are
shown in Table 8.
Pearson correlation analysis between the dose at the
scan center and the thyroid and uterus surface dose
showed that there is a significant correlation between the
two; therefore, linear regression analysis was applied. The
results of the regression analysis are listed in Table 9.
Therefore, we can measure the dose at the scan center
and assess the dose to critical organs. Also, there was a
significant correlation (a correlation coefficient of 0.94 and
a p-value < 0.001) between the thyroid and uterus surface
doses in both the PA spinal and femur scan modes. The
average distances from the thyroid and uterus to the edge
of the PA spine scan were 37.18 and 26.39 cm, respec-
tively. The distances from the thyroid and uterus in the
femur scan were 59.47 and 6.27 cm, respectively. The
percentage the surface dose of the thyroid and uterus
organs with respect to the center of scan dose is shown in
Table 10.
Finally, we used phantom linear regression functions to
estimate the depth dose according to the surface dose in
the patients. The results are listed in Table 11. After
Absorbed Organ Dose in Dual X-ray Absorptiometry
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Table 7.  Linear Regression Functions and Correlation
Coefficients for Independent Variable of Surface
Dose (Ds) and Dependent Variable of Depth Dose
(Dd) for Uterus at Different Depths
Linear Regression Correlation  Significant 
Function Coefficient Level
D22.0 = 1.54 Ds 0.56 0.87 0.000
D14.5 = 0.90 Ds+0.53 0.93 0.006
D9.5 = 1.48 Ds+0.74 0.97 0.002
Table 8. Mean and Standard Deviation of Surface Dose (Ds)
of Thyroid, Uterus, Center of Scan and Background
in PA Spine and Femur Scan Modes for 40 Women
(Patients) with Using 120 TLDs ( Gy)
Ds Ds Center of 
Thyroid Uterus Scan 
Background
1.88  1.36 1.81  1.03 5.70  2.38 1.45  0.98
Table 9. Linear Regression Functions and Correlation
Coefficients for Independent Variable of Surface
Dose (Ds) and Dependent Variable of Center of
Scan Dose (Dc)
Linear Regression  Correlation  Significant 
Function Coefficient Level
Ds (Thyroid) = 0.40 Dc 0.38 0.55 0.000
Ds (Uterus) = 0.27 Dc+0.38 0.69 0.000
Table 10. Mean and Standard Deviation of Percentage of
Surface Dose of Thyroid and Uterus Organs with
Respect to Center of Scan Dose (Dc)
Percent of Relative  Percent of Relative 
Dc( Gy) Absorbed Dose Absorbed Dose
(Thyroid) (Uterus)
5.70  2.38 33  13 35  13
Table 6. Mean and Standard Deviation of Surface Dose (Ds: Near Source) and Depth Dose (Dd; depth length, cm) at 9.5, 10.5,
11.5, 12.5 (Center of Uterus), 14.5, 15.5, 16.5, 17.5 (above Uterus) and 22.0 cm from Surface ( Gy) (n = 15)
Dd (0) Dd (9.5) Dd (10.5) Dd (11.5) Dd (12.5) Dd (14.5) Dd (15.5) Dd (16.5) Dd (17.5) Dd (22.0)
2.27 0.88 2.40 1.42 3.49 0.73 2.89 0.35 2.74 0.13 2.45 0.89 4.52 1.31 2.87 0.08 3.22 0.41 2.93 1.56applying X-ray quality factor and thyroid and uterus
weighting factors (0.05), the mean thyroid contribution to
the effective dose was found to be 0.08  Sv. The uterus
contribution was 0.13  Sv in the PA spinal scan mode and
0.14  Sv in the femur scan mode.
DISCUSSION
The measured surface doses of the thyroid and uterus
and the dose at the scan center in both the PA spine and
femur scan modes were smaller than the manufacturer’s
quoted values of 9.6  Gy (17). Also, these values are much
lower than the average daily background in the United
Kingdom of 7  Sv (18). 
In this study, there was a significant correlation between
the dose at the scan center and the thyroid and uterus
surface doses (p-value < 0.01) (Fig. 5).
There was also a significant correlation between the
thyroid and uterus surface doses (p-value < 0.05) (Fig. 6).
After regression analysis, the linear regression function
between the thyroid surface dose (Ds [thyroid]) and the
uterus surface dose (Ds [uterus]) was described by
Ds (thyroid) = Ds (uterus) 0.91 0.01
Based on the fact that the system has a pencil beam and
the absorbed dose to the critical organs is due to scattered
radiation, the significant correlation between the dose at
the scan center and the organs’ surface doses is remark-
able. During the PA spine scan, for the phantom measure-
ments, the absorbed doses to the uterus and the left and
Mokhtari-Dizaji et al.
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Table 11. Estimation of Depth Dose of Thyroid and Uterus Organs (Dd; depth length, cm) based on Their Surface Dose ( Gy)
with Using Extracted Linear Regression Functions of Phantom
Uterus Uterus Thyroid
Femur Scan Mode PA Spine Scan Mode PA Spine Scan Mode
Dd (9.5) Dd (14.5) Dd (22.0) Dd (12.5) Dd (17.5) Dd (22.0) Left lobe Right lobe
3.42 1.52 2.23 1.23 2.23 1.59 1.85 0.97 2.30 1.57 1.67 0.78 1.51 0.64 1.69 0.78
Fig. 6. Scatter plot between uterus surface dose and thyroid
surface dose ( Gy) with 95% confidence interval. 
Fig. 5. Scatter plot between centers of scan dose with thyroid surface dose (A) and uterus surface dose ( Gy) (B) with 95% confidence
interval. 
ABright lobes of the thyroid were 1.21 0.33, 1.28 0.25 and
1.18 0.17  Gy, respectively. The average uterus surface
dose in the femur scan was 2.52 1.12  Gy. Because the
thyroid dose was on the same order of magnitude as the
background, it was not considered in this protocol. The
surface dose at the scan center was 7.38 2.27  Gy. All of
these values are smaller than those the manufacturer
reported for this scan mode (17). The contribution of the
uterus, ovaries and the left and right thyroid on the
effective dose in the PA spine scan was 0.06 0.02, 0.24
0.07, 0.06 0.01 and 0.06 0.02  Sv, respectively. In the
femur scan, the contributions of the uterus and ovaries to
the effective dose were 0.13 0.06 and 0.50 0.22  Sv,
respectively. We found a significant correlation between
the surface and depth doses in the thyroid and uterus with
the PA spinal scan. There was also a significant correlation
between the uterus surface and depth doses in the femur
scan.
In another study, the dosimetry of Hologic QDR-1000
systems having a pencil beam and the Hologic QDR-2000
systems having a fan beam was determined with results
similar to those obtained in the present study (19). Njeh et
al. (13) measured the thyroid and gonadal doses in the
lunar DPX-L system and they showed that the contribu-
tions of the thyroid and gonadal doses to the effective dose
were about zero; the dose at the scan center was 6  Gy. If
we consider the TLD error in this energy range, our results
are in the same range as those of this prior study. 
Steel et al. (4) worked on lunar Expert-XL systems. Their
reported contribution of the uterus to the effective dose
was larger than the present study, which could be due to
the differences in the output beam properties (fan beam:
143 kVp). For a Hologic QDR-2000 system, the contribu-
tion of the uterus and ovaries to the effective dose was
larger than our results because this system uses a fan beam
(16). Koo et al. (20) reported that the surface dose at the
scan center for children is 3  Gy, which was smaller than
the value obtained in the present study (6.5  Gy). The
absorbed doses to a fetus phantom in the first trimester
with a pencil beam scanning the femur and PA spine were
2.7 and 1.2  Gy, respectively. During the 2nd and 3rd
trimesters, the absorbed doses were 2.7 and 4.9  Gy,
respectively, for the PA spine scan and 1.4 and 1  Gy,
respectively, for the femur scan (11).
One source of error in this study was variance in the
photon density and TLD precision. We found a significant
correlation between the thyroid and uterus surface doses
and the scan center dose. We also estimated the depth dose
from the surface dose. The percentage of the surface dose
with respect to the dose at the scan center shows that the
thyroid and uterus receive 33% and 35% of the dose to
the scan center, respectively. The contribution of the
effective dose equivalent from the DXA shows that the
dose values of DXA are smaller than those of radiographic
experiments (21). 
After acquisition of dose values, correlations between
the dose at the scan center and the surface dose at critical
organs were assessed. The correlation between the surface
dose and the scan center dose existed in the patient studies,
but not in the phantom studies. Comparing the organ dose
with the dose at the scan center in the phantom showed
that there was no significant correlation between these two
parameters. The fact that no relation existed between the
critical organs’ absorbed dose and the dose at the scan
center could be due to the pencil beam in the system.
Therefore, for the phantom measurements, we suggest
using a larger sample to assess the correlation between the
surface doses and scan center dose. Moreover these organs
aren’t in the scan direction; therefore, their absorbed dose
was due to scattered radiation from other tissues. 
Our results showed that exposure in bone densitometry
with a lunar DPX-MD was low at the level of the daily
background dose. Therefore, the use of this system in a
periodic manner should be of a low risk. We were able to
estimate the thyroid, uterus and ovarian absorbed doses by
measuring the dose at the scan center and the associated
organ surface doses. 
References
1. Blinov NN, Gubenko MB and Utkin PM. Development of
osteodensitometric equipment. Biomed Eng 2002;36:36-40
2. Diez F. Guidelines for the diagnosis of osteoporosis by densito-
metric methods. J Manipulative Physiol Ther 2002;25:403-415
3. Boudousq V, Kotzki PO, Dinten JM, Barrau C, Robert-Coutant
C, Thomas E, et al. Total dose incurred by patients and staff
from BMD measurement using a new 2D digital bone densito-
meter. Osteoporos Int 2003;14:263-269
4. Steel SA, Baker AJ, Saunderson JR. An assessment of the
radiation dose to patients and staff from a Lunar Expert-XL fan
beam. Physiol Meas 1998;19:17-26
5. Eiken P, Barenholdt O, Jensen LB, Gram J, Nielson SP.
Switching from DXA pencil beam to fan beam. I:  studies in
vitro at four centers. Bone 1994;15:667-670
6. Eiken P, Kolthoff N, Barenholdt O, Hermansen H, Nielson SP.
Switching from DXA pencil beam to fan beam. II: studies in
vivo. Bone 1994;15:671-676
7. Royal college of radiologist and national radiological protection
board. Patient dose reduction in diagnostic radiology
(documents of the NRPB). 1991;London: HMSO, 1:3
8. Popovic M, McNiell FE, Webber CE, Chettle DR. The effect of
lead in bone densitometry. Nuclear Instruments and Methods in
Physics Research Section B 2004;213:599-602
9. Culton N, Pocock N. Evaluation of three spine phantoms for
DXA QC. Bone 2000;27:48S
10. Dequeker J, Pearson J, Reeve J, Henley M, Bright J, Felsenberg
D, et al. Dual x-ray absorptiometry--cross-calibration and
normative reference ranges for the spin: results of a European
Absorbed Organ Dose in Dual X-ray Absorptiometry
Korean J Radiol 9(2), April 2008 109Mokhtari-Dizaji et al.
110 Korean J Radiol 9(2), April 2008
Community Concerted Action. Bone 1995;17:247-254
11. Kalender WA, Felsenberg D, Genant HK, Fischer M, Dequeker
J, Reeve J. The European Spine Phantom-a tool for standardiza-
tion and quality control in spinal bone mineral measurements by
DXA and QCT. Eur J Radiol 1995;20:83-92
12. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H. Cross
calibration of QDR-2000 and QDR-1000 dual energy X-ray
densitometers for bone mineral and soft-tissue measurements.
Bone 1995;16:385-390
13. Njeh CF, Samat SB, Nightingale A, McNeil EA, Boivin CM.
Radiation dose and in vitro precision in paediatric bone mineral
density measurement using dual X-ray absorptiometry. Br J
Radiol 1997;70:719-727
14. Njeh CF, Apple K, Temperton DH, Boivin CM. Radiological
assessment of a new bone densitometer-the Lunar EXPERT. Br
J Radiol 1996;69:335-340
15. Blake GM, Patel R, Lewis MK, Batchelor S. New generation
dual X-ray absorptiometry: a comparison of pencil beam and
fan beam systems. Br J Radiol 1996;11:S157
16. Damilakis J, Perisinakis K, Vrahoriti H, Kontakis G, Varveris H,
Gourtsoyiannis N. Embryo/fetus radiation dose and risk from
dual X-ray absorptiometry examinations. Osteoporos Int
2002;13:716-722
17. Buroker KD. DPX series operator’s manual, 1998:45-80
18. Hughes JS, Shaw KB, O’Riordan MC. Radiation exposure of the
UK population: 1988 review. National Radiation Protection
Board (Report NRPB-R227) 1989;London: HMSO 32-36
19. Boutros M. Radiation dose assessment to patients and staff
from the new LEXXOS bone dosimeter MSc thesis in Medical
Engineering and Physics 2003; King’s collage London: 45-63
20. Koo WW, Walters J, Bush AJ. Technical considerations of dual-
energy X-ray absorptiometry-based bone mineral measurements
for pediatric studies. J Bone Miner Res 1995;10:1998-2004
21. Hart D, Jones DG, Wall BF. Coefficient for estimating effective
doses from paediatric x-ray examinations (NRPB-R279).
1996;London: HMSO 24-27